4//SEC Filing
de Notaristefani Carlo 4
Accession 0001209191-19-031609
CIK 0000818686other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 6:38 AM ET
Size
9.5 KB
Accession
0001209191-19-031609
Insider Transaction Report
Form 4
de Notaristefani Carlo
Executive VP Global Operations
Transactions
- Exercise/Conversion
Ordinary Shares
2019-05-18+30,875→ 49,658.727 total - Sale
Ordinary Shares
2019-05-20$11.42/sh−16,070$183,519→ 33,588.727 total - Exercise/Conversion
Restricted Share Units
2019-05-18−30,875→ 0 total→ Ordinary Shares (30,875 underlying)
Footnotes (5)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F4]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II.
- [F5]Restricted share units were granted on May 18, 2017 and vested on May 18, 2019.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001719114
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 6:38 AM ET
- Size
- 9.5 KB